Evidence map›Paper›PMID 40791724›Full record

ArticlemedRxiv : the preprint server for health sciences2025

An unbiased comparison of 14 epigenetic clocks in relation to 10-year onset of 174 disease outcomes in 18,859 individuals.

Christos Mavrommatis, Daniel W Belsky, Kejun Ying, Mahdi Moqri, Archie Campbell, Anne Richmond, Vadim N Gladyshev, Tamir Chandra, Daniel L McCartney, Riccardo E Marioni

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Christos MavrommatisCentre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, UK.
Daniel W BelskyRobert N Butler Columbia Aging Center & Department of Epidemiology, New York, NY, USA.ORCID 0000-0001-5463-2212
Kejun YingDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mahdi MoqriDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6675-0566
Archie CampbellCentre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, UK.
Anne RichmondCentre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, UK.
Vadim N GladyshevDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tamir ChandraRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Daniel L McCartneyCentre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, UK.
Riccardo E MarioniCentre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, UK.

Funding

The MyGoals for Healthy Aging Multi-Center Randomized Controlled TrialR01AG073402 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Daniel Walker Belsky · 2022 to 2026
$3.6M
Testing effects of cash transfers on biological aging and risk for Alzheimer's DiseaseR01AG087158 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Allison E Aiello, Daniel Walker Belsky · 2024 to 2026
$1.9M
NIA NIH HHS R01 AG073402NIA NIH HHS R01 AG087158Wellcome Trust
6 · The paper itself

Abstract

Epigenetic Clocks have been trained to predict chronological age, healthspan and lifespan. Such clocks are often analysed in relation to disease outcomes - typically using small datasets and a limited number of clocks. Here, we present the first large-scale (n=18,849), unbiased comparison of 14 widely used clocks as predictors of 174 incident disease outcomes and all-cause mortality. Second-generation clocks significantly outperformed first-generation clocks, which have limited applications in disease settings. Of the 176 Bonferroni significant (P<0.05/174) associations, there were 27 diseases (including primary lung cancer and diabetes) where the hazard ratio for the clock exceeded the clock's association with all-cause mortality. Furthermore, there were 35 instances where adding a clock to a null classification model with traditional risk factors increased the classification accuracy by >1% with an AUC

Identifiers

PMID40791724
PMCPMC12338881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.